ADMA Biologics
ADMA
#2889
Rank
A$7.13 B
Marketcap
$30.18
Share price
0.00%
Change (1 day)
307.90%
Change (1 year)

ADMA Biologics (ADMA) - Cash on Hand

Cash on Hand as of September 2024 : A$0.14 Billion

According to ADMA Biologics 's latest financial reports the company has A$0.14 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

ADMA Biologics - Cash on Hand chart (from 2010 to 2024)

2013201620192022$50M$0.1B$0.15B$0.2B0companiesmarketcap.com

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$75.37 M-40.72%
2022-12-31A$0.12 B80.42%
2021-12-31A$70.46 M-3.1%
2020-12-31A$72.72 M90.33%
2019-12-31A$38.2 M18.29%
2018-12-31A$32.3 M-41.5%
2017-12-31A$55.21 M160.05%
2016-12-31A$21.23 M-7.98%
2015-12-31A$23.07 M-13.58%
2014-12-31A$26.7 M-18.11%
2013-12-31A$32.6 M170.31%
2012-12-31A$12.06 M
2011-06-30A$0 M-44.24%
2010-06-30A$0.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.47 B 948.97%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.27 B 804.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.62 M-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA